APIs pour la recherche et les impuretés
Les principes actifs pharmaceutiques (API) sont les substances présentes dans les médicaments qui sont responsables de leurs effets thérapeutiques. Dans cette section, vous trouverez une grande variété d'API destinés à un usage de recherche. Ces composés sont essentiels pour le développement, les tests et la validation de nouvelles formulations pharmaceutiques. Chez CymitQuimica, nous proposons des API de haute qualité pour soutenir la recherche dans la découverte et le développement de médicaments.
Sous-catégories appartenant à la catégorie "APIs pour la recherche et les impuretés"
- Acides Aminés et Dérivés(12.270 produits)
- Anthraquinones et Dérivés(405 produits)
- Dérivés du Benzimidazole et de l’Imidazole(10.354 produits)
- Dérivés des Benzodiazépines(333 produits)
- Glucides et Glycoconjugués(5.010 produits)
- Esters et Dérivés(42.026 produits)
- Acides Gras et Dérivés Lipidiques(32.215 produits)
- Flavonoïdes et Polyphénols(16.999 produits)
- Radicaux Libres et Agents Oxydants/Réducteurs(213 produits)
- Cétones et Dérivés(2.393 produits)
- Antibiotiques Naturels et Semi-Synthétiques(6.347 produits)
- Nitriles et Dérivés Cyano(3.042 produits)
- Nitrosamines et Dérivés(55 produits)
- Nucléosides et Nucléotides(3.421 produits)
- Phosphates et Phosphonates Organiques(1.201 produits)
- Sulfonates et Sulfates Organiques(10.393 produits)
- Composés Organométalliques(4.401 produits)
- Autres(6.275 produits)
- Peptides et Protéines(3.121 produits)
- Polymères et Dérivés(99 produits)
- Dérivés des Purines et Pyrimidines(8.898 produits)
- Dérivés de Quinazoline et de Quinoléine(65.578 produits)
- Quinones et Dérivés(24.205 produits)
- Sels et Dérivés d’API(79.383 produits)
- Stéroïdes et Dérivés(4.948 produits)
- Sulfamides et Dérivés(2.589 produits)
- Terpénoïdes et Dérivés(3.837 produits)
- Thiazolidinediones et Thiopyranes(2.733 produits)
- Composés β-Adrénergiques(230 produits)
Affichez 21 plus de sous-catégories
56681 produits trouvés pour "APIs pour la recherche et les impuretés"
Trier par
Degré de pureté (%)
0
100
|
0
|
50
|
90
|
95
|
100
Vortioxetine Impurity 19
CAS :<p>3-Indoxyl β-D-galactopyranoside, 6-fluoro-3-indoxyl β-D-galactopyranoside, Tilmicosin, 3-Desacetylcefotaxime potassium, Gatifloxacin, Vortioxetine Impurity 19</p>Formule :C18H22N2OSDegré de pureté :Min. 95%Masse moléculaire :314.4 g/molMycophenolate mofetil EP impurity B oxalate
CAS :<p>Please enquire for more information about Mycophenolate mofetil EP impurity B oxalate including the price, delivery time and more detailed product information at the technical inquiry form on this page</p>Formule :C29H42N2O9•C2H2O4Degré de pureté :Min. 95%Masse moléculaire :652.68 g/molMycophenolate mofetil EP Impurity C
CAS :<p>Please enquire for more information about Mycophenolate mofetil EP Impurity C including the price, delivery time and more detailed product information at the technical inquiry form on this page</p>Formule :C23H31NO7Degré de pureté :Min. 95%Masse moléculaire :433.5 g/molIvermectin impurity I
CAS :<p>Ivermectin impurity I is an analytical standard that is used for pharmacopoeia and custom synthesis. It is a natural metabolite of the drug Ivermectin, which has been shown to have anti-inflammatory properties in mice. Ivermectin impurity I binds to nicotinic acetylcholine receptors, leading to muscle paralysis and death. This compound is found in high purity for research and development purposes.</p>Formule :C48H74O14Degré de pureté :Min. 95%Couleur et forme :PowderMasse moléculaire :875.09 g/mol2,3,4,5-Tetradehydro alfuzosin hydrochloride
CAS :<p>Alfuzosin is a potent, selective, and long-acting α1A-adrenergic receptor antagonist. It is used to treat benign prostatic hyperplasia (BPH) in males. Alfuzosin is also used as an antihypertensive agent, for the treatment of pheochromocytoma, and for the treatment of benign prostatic hyperplasia in males. The hydrogenation of 2,3,4,5-tetradehydroalfuzosin to alfuzosin hydrochloride is performed by liquid hydrogenation or by hydrogenation on a palladium catalyst in a mixture of dimethylformamide and hexamethylphosphoramide. This process minimizes the formation of impurities such as 2,3,4-trimethoxy alfuzosin.</p>Formule :C19H24ClN5O4Degré de pureté :Min. 95%Couleur et forme :White PowderMasse moléculaire :421.88 g/molAmlodipine EP Impurity F maleate
CAS :<p>Amlodipine EP Impurity F maleate is an impurity of amlodipine, a drug product. It is a natural substance that has been classified as an API impurity in the United States Pharmacopeia (USP). The chemical name for this drug is 3-(2-chlorophenyl)-1-methyl-5-(o-tolyloxy)-2,4-dihydro-6H-[1,3]thiazolo[3,2-a]pyrimidin-7-one. Amlodipine EP Impurity F maleate has the following properties: C12H9ClNO2S and a melting point of 210°C with a purity of 99.5%. This compound was synthesized by custom synthesis and is used as an analytical standard for HPLC. This compound was also used during the development of amlodipine to determine its metabolism studies.</p>Formule :C19H23ClN2O5•C4H4O4Degré de pureté :Min. 95%Masse moléculaire :510.92 g/molAmoxicillin EP Impurity D
CAS :<p>Amoxicillin EP Impurity D is a metabolite of amoxicillin that is generated through the metabolism of the drug by enzymes in the body. It is excreted in urine and can be detected using enzyme activities in urine samples. Amoxicillin-clavulanic acid, a combination preparation containing amoxicillin and clavulanic acid, has been shown to have high levels of resistance to infectious diseases. Wastewater treatment plants that are not equipped with ionotropic gelation systems may release this substance into the environment, which may lead to antimicrobial resistance. Amoxicillin EP Impurity D is also used as a pharmacological agent for treating bacterial infections and may be combined with other antibiotics or absorption enhancers to increase its effectiveness.</p>Formule :C16H21N3O6SDegré de pureté :Min. 95%Masse moléculaire :383.42 g/mol3-Chloro-4-hydroxyacetanilide
CAS :<p>3-Chloro-4-hydroxyacetanilide is a chemical compound that belongs to the class of acetanilides. It has long-term toxicity and is used as a drug substance in the production of aniline derivatives. 3-Chloro-4-hydroxyacetanilide has been shown to be carcinogenic in hamsters. The long term exposure to this chemical was shown to cause liver damage and increased incidence of tumours in rats. This drug also contains impurities and traces of chloride, chlorine, and thionyl chloride, which are toxic substances that can cause irritation or burns on contact with skin or eyes.</p>Formule :C8H8ClNO2Degré de pureté :Min. 95%Masse moléculaire :185.61 g/mol3-Trifluoroacetylamino linagliptin
CAS :<p>Please enquire for more information about 3-Trifluoroacetylamino linagliptin including the price, delivery time and more detailed product information at the technical inquiry form on this page</p>Formule :C27H27F3N8O3Degré de pureté :Min. 95%Masse moléculaire :568.55 g/molSitagliptin monohydrochloride monohydrate
CAS :<p>Sitagliptin monohydrochloride monohydrate is an inhibitor of dipeptidyl peptidase-4 (DPP-4), which is responsible for the degradation of incretin hormones. It is used in the treatment of type 2 diabetes mellitus, as it increases insulin secretion and reduces blood glucose levels. Recent studies have shown that Sitagliptin has anticancer properties, as it induces apoptosis in cancer cells. It also inhibits protein kinases, which are involved in tumor growth and metastasis. Capsaicin, a compound found in chili peppers, has been shown to enhance the anticancer activity of Sitagliptin in Chinese hamster ovary cells. The drug is excreted primarily through urine and has a low potential for drug interactions with other kinase inhibitors. Overall, Sitagliptin monohydrochloride monohydrate shows great promise as both a diabetes medication and an anticancer agent.</p>Formule :C16H18ClF6N5O2Degré de pureté :Min. 95%Couleur et forme :PowderMasse moléculaire :461.79 g/mol(2S,3R,5S)-5-[(N-Formyl-L-leucyl)oxy]-2-hexyl-3-hydroxyhexadecanoic acid
CAS :<p>Orlistat is a lipase inhibitor that is used as a weight-loss drug. It works by inhibiting the absorption of dietary fats and their subsequent conversion into triglycerides in the intestines, thereby limiting the calories absorbed. Orlistat has been shown to be effective in lymphatic and fatty acid transport, but oral bioavailability is low due to extensive first-pass metabolism. Orlistat inhibits pancreatic lipase, which may lead to reduced intestinal fat absorption and decreased systemic exposure. This drug also inhibits long-chain fatty acids from being absorbed through the intestinal wall and prevents them from being metabolized, thereby reducing lipid formulations in the blood.</p>Formule :C29H55NO6Degré de pureté :Min. 95%Masse moléculaire :513.75 g/molα-Hydroxy olopatadine hydrochloride
CAS :<p>Olopatadine is an antihistamine that is used to treat allergic rhinitis and seasonal allergic conjunctivitis. It is an α-hydroxy acid metabolite of the arylacetic acid group. This drug has been shown to inhibit the metabolism of olopatadine in humans, which may result in reduced potency for this drug. Olopatadine hydrochloride is used as a standard for quantitative analysis by high performance liquid chromatography (HPLC) and can be used as an impurity standard for preparing synthetic olopatadine. It is also used in drug development and research, such as evaluating its pharmacological properties and investigating its potential role in treating other ocular conditions such as dry eye syndrome.</p>Formule :C21H23NO4•HClDegré de pureté :Min. 95%Couleur et forme :PowderMasse moléculaire :389.9 g/molStigmastanol
CAS :<p>Stigmastanol is a phytosterol isolated from Hypericum riparium, which is a Cameroonian medicinal plant.</p>Formule :C29H52ODegré de pureté :98.07%Couleur et forme :SolidMasse moléculaire :416.72OMDM-5
CAS :<p>OMDM-5 is a potent vanilloid receptor type 1 (TRPV1, EC50 = 75 nM) agonist, showing weak ligand activity at cannabinoid type 1 receptor (CB1, Ki=4.9 μM).</p>Formule :C26H44N2O3Degré de pureté :99.73%Couleur et forme :SolidMasse moléculaire :432.64Pidotimod diketopiperazine-6-propanoic acid
CAS :<p>Pidotimod is an impurity in the drug product, which is a synthetic diketopiperazine-6-propanoic acid. Pidotimod is an impurity standard that is used in the development of drugs and as a pharmacopoeia. It has been shown to be metabolized by human liver microsomes and human erythrocytes.</p>Formule :C9H12N2O4SDegré de pureté :Min. 95%Masse moléculaire :244.27 g/mol7'-Methyl-2'-propyl-2,5'-bi-1H-benzimidazole
CAS :<p>7'-Methyl-2'-propyl-2,5'-bi-1H-benzimidazole (7'-MPB) is a benzimidazole derivative that is used as a medicine. It is made from recycled chemicals and has shown to have industrial applications as a catalyst for cyclization reactions. 7'-MPB is also used in the production of benzenesulfonic acid, which is an organic solvent. This chemical has been shown to be effective against high blood pressure, but has not been tested on humans yet. Telmisartan, which belongs to the angiotensin II receptor blocker class of drugs, can inhibit the synthesis of prostaglandins.</p>Formule :C18H18N4Degré de pureté :Min. 95%Masse moléculaire :290.36 g/molDesfluoro ciprofloxacin hydrochloride
CAS :<p>Fluoroquinolones are a class of antibiotics that are used to treat bacterial infections. Desfluoro ciprofloxacin hydrochloride is a fluorinated derivative of ciprofloxacin and is an ultra-fast synthetic compound. It has been shown to be more potent than the parent molecule. This drug is considered to be impure because it contains other chemical compounds, such as isomers and back-pressure products. The particle size distribution of desfluoro ciprofloxacin hydrochloride is usually very broad with diameters ranging from 5 nm to 1 micron. It can be separated by particle size in a phase liquid chromatography column because the particles have different hydrodynamic diameters. Desfluoro ciprofloxacin hydrochloride can also be separated by phase chromatography on an oligosaccharide column, which produces more efficient separation than traditional high-performance liquid chromatography (HPLC).</p>Formule :C17H19N3O3·HClDegré de pureté :Min. 95%Couleur et forme :Off-White PowderMasse moléculaire :349.81 g/molDesogestrel Related Compound A
CAS :<p>Desogestrel Related Compound A is a synthetic impurity standard. It is the metabolite of desogestrel, which belongs to the drug class progestins and is used for contraception. Desogestrel Related Compound A is used as a research and development or impurity standard for pharmacopoeia-grade drugs or custom synthesis with high purity. The CAS number for this product is 201360-82-9.</p>Formule :C22H30ODegré de pureté :Min. 95%Couleur et forme :PowderMasse moléculaire :310.47 g/molGly-OH9-Oxytocin
CAS :<p>Oxytocin impurity</p>Formule :C43H65N11O13S2Masse moléculaire :1,008.18 g/mol2-(Methoxymethyl)-5-(phenylthio)-1H-benzimidazole
CAS :<p>2-(Methoxymethyl)-5-(phenylthio)-1H-benzimidazole is a drug product that is used in research and development. It is an analytical standard for the impurity 2-(Methoxymethyl)-5-phenylthio-1H-benzimidazole, which has a natural origin. The impurity standard can be used to assess the purity of the API by HPLC. This drug product is also used as a Metabolism studies and Natural standards. These standards are used to study the metabolism of drugs, which can lead to new insights into their therapeutic action and toxicity. 2-(Methoxymethyl)-5-(phenylthio)-1H-benzimidazole can be synthesized in custom synthesis or synthetic methods. It has been shown to have niche uses in drug development, research and development, and analytical chemistry.</p>Formule :C15H14N2OSDegré de pureté :Min. 95%Masse moléculaire :270.4 g/molSumatriptan 3-hydroxy-2-oxo impurity
CAS :<p>Please enquire for more information about Sumatriptan 3-hydroxy-2-oxo impurity including the price, delivery time and more detailed product information at the technical inquiry form on this page</p>Formule :C14H21N3O4SDegré de pureté :Min. 95%Masse moléculaire :327.4 g/mol4-[(2RS)-2-Hydroxy-3-[(1-methylethyl)amino]propoxy]-benzaldehyde hydrochloride
CAS :<p>4-[(2RS)-2-Hydroxy-3-[(1-methylethyl)amino]propoxy]-benzaldehyde hydrochloride is a drug product. It is used as an analytical standard and in the development of drugs. The metabolite of 4-[(2RS)-2-Hydroxy-3-[(1-methylethyl)amino]propoxy]-benzaldehyde hydrochloride, 4-[(2RS)-2-hydroxy-3-[(1-methylethyl)amino]propoxy]-N-(4-nitrophenyl)benzamide, has been shown to inhibit the production of cytokines IL6 and TNFα by human monocytes, macrophages, and dendritic cells. Metabolism studies have shown that 4-[(2RS)-2-hydroxy-3-[(1-methylethyl)amino]propoxy]-N</p>Formule :C13H20ClNO3Degré de pureté :Min. 95%Masse moléculaire :273.76 g/molQuetiapine ep impurity P
CAS :<p>Quetiapine ep impurity P is a metabolite of quetiapine. It is a synthetic compound with pharmacopoeia and analytical standards available. Quetiapine ep impurity P is used in research and development to study the metabolism of quetiapine, but it also has niche uses in drug product development. Quetiapine ep impurity P can be synthesized by high-purity custom synthesis or natural methods, such as from plants.</p>Formule :C19H21N3SDegré de pureté :Min. 95%Masse moléculaire :323.5 g/mol14-Hydroxy clarithromycin
CAS :<p>14-Hydroxy clarithromycin is an analog of clarithromycin that has been shown to have anticancer properties. It is excreted in urine and has been found to inhibit several kinases, including cyclin-dependent kinases and protein kinase C. This drug induces apoptosis in cancer cells and inhibits tumor growth in Chinese hamsters. 14-Hydroxy clarithromycin has also been studied as a potential inhibitor of the human kinase, which may have implications for the development of new cancer therapies. Overall, this drug shows promise as an effective anticancer agent with potential for further research and development.</p>Formule :C38H69NO13Degré de pureté :Min. 95%Masse moléculaire :748 g/molChlorthalidone impurity E
CAS :<p>Chlorthalidone impurity E is an analytical standard for the HPLC analysis of chlorthalidone in pharmaceutical drug products and is a metabolite of chlorthalidone. Chlorthalidone impurity E is an API impurity that can be found in the synthesis of chlorthalidone, and it has been detected as a minor component in certain drug products. It is important to have an accurate specification for this compound, since it can affect the pharmacological properties of the drug product. The purity level of this compound must be at least 98% or greater to ensure that there are no contaminants present. This compound is also a metabolite of chlorthalidone and is used as a pharmacopoeia reference substance for testing equipment calibration.END></p>Formule :C14H11ClN2O3SDegré de pureté :Min. 95%Masse moléculaire :322.77 g/molN-Hydroxy sertraline
CAS :<p>N-Hydroxy sertraline is a metabolite of the antidepressant drug, sertraline. It is formed by the action of cytochrome P450 enzymes in the liver. N-Hydroxy sertraline is not active as an antidepressant, but it may have some activity against bacterial infections. There are no pharmacopoeia standards for this compound.</p>Formule :C17H17Cl2NODegré de pureté :Min. 95%Masse moléculaire :322.20 g/molAcarbose EP Impurity H
CAS :<p>Acarbose EP Impurity H is an impurity of acarbose, a drug product used in the treatment of type II diabetes. Acarbose is a natural product and its synthesis starts from a chemical called alpha-D-glucopyranosyl-3-O-[2,4,6-trichloro-3-(trifluoromethyl)phenyl]pyridine. Acarbose is metabolized by the liver to form Acarbose EP Impurity H. The metabolism studies of this impurity have shown that it has niche pharmacological properties. Acarbose EP Impurity H can be used as an analytical or API impurity for HPLC standard or as a synthetic intermediate for pharmaceutical research and development.</p>Formule :C25H43NO17Degré de pureté :Min. 95%Masse moléculaire :629.61 g/mol2,2',4,4',6,6'-Hexachlorobiphenyl
CAS :Produit contrôlé<p>2,2',4,4',6,6'-Hexachlorobiphenyl (PCB-136) is a potent anticancer agent that has been shown to induce apoptosis in cancer cells. It acts as a kinase inhibitor by blocking the activity of specific kinases involved in tumor growth and progression. PCB-136 has been studied extensively in human and Chinese hamster ovary cells and has been found to be highly effective against various types of cancer. This medicinal analog also exhibits inhibitory effects on the protein kinases that regulate cell division and proliferation, making it a promising candidate for cancer therapy. In addition, PCB-136 shows potential for use as a urinary biomarker for exposure to environmental pollutants due to its persistence in the environment and ability to accumulate in body tissues.</p>Formule :C12H4Cl6Degré de pureté :Min. 95%Masse moléculaire :360.9 g/mol[O1-Trp25]-Tirzepatide
<p>Tirzepatide impurity.</p>Formule :C225H348N48O69Masse moléculaire :4,829.53 g/molD-6-Cyano-6-norlysergic acid methyl ester
CAS :<p>Please enquire for more information about D-6-Cyano-6-norlysergic acid methyl ester including the price, delivery time and more detailed product information at the technical inquiry form on this page</p>Formule :C17H15N3O2Degré de pureté :Min. 95%Masse moléculaire :293.32 g/mol6-Oxo mometasone furoatemometasone furoate impurity F
CAS :<p>6-Oxo mometasone furoatemometasone furoate impurity F is a drug product that is an impurity standard for the synthesis of 6-oxo mometasone furoatemometasone furoate. This impurity has been shown to have a metabolite profile similar to that of 6-oxo mometasone furoatemometasone furoate, but with a different retention time in HPLC analysis. It has also been shown to be present in natural products and to inhibit metabolism studies. This impurity should be used as an analytical standard for HPLC analysis of 6-oxo mometasone furoatemometasone furoate.</p>Formule :C27H28Cl2O7Degré de pureté :Min. 95%Masse moléculaire :535.4 g/mol1-(6-Chloro-9H-carbazol-2-yl)ethanone
CAS :<p>1-(6-Chloro-9H-carbazol-2-yl)ethanone is a chemical substance that belongs to the class of synthetic drugs. It is used as a pharmaceutical intermediate in the production of other chemical substances, including antibiotics and antihypertensives. 1-(6-Chloro-9H-carbazol-2-yl)ethanone has been shown to be metabolized by cytochrome P450 enzymes and by glucuronidases or esterases. This product can also be used as an impurity standard for HPLC analyses of fluoroquinolones.</p>Formule :C14H10ClNODegré de pureté :Min. 95%Masse moléculaire :243.69 g/molAcarbose EP Impurity G
CAS :<p>Acarbose EP Impurity G is a pharmaceutical grade impurity that is used as a reference standard for HPLC and LC-MS analysis. Acarbose EP Impurity G is a metabolite of acarbose and can be found in human plasma. It has been shown that Acarbose EP Impurity G induces the metabolism of glucose, which may be due to its ability to inhibit the activity of alpha-glucosidase. Acarbose EP Impurity G also inhibits the activity of pancreatic beta-cells, leading to impaired insulin secretion.</p>Formule :C31H53NO23Degré de pureté :Min. 95%Masse moléculaire :807.75 g/molHylocerenin
CAS :<p>Hylocerenin is a medicinal compound that shows promise as an anticancer agent. It is a protein kinase inhibitor, which means it can prevent the growth and spread of cancer cells. Hylocerenin is derived from Chinese herbal medicine and is an analog of a natural compound found in urine. Studies have shown that hylocerenin induces apoptosis or programmed cell death in tumor cells, making it a potential treatment for cancer. This compound has been tested on human cancer cell lines and has demonstrated its effectiveness as a kinase inhibitor, making it a promising candidate for future cancer treatments.</p>Formule :C30H34N2O17Degré de pureté :Min. 95%Masse moléculaire :694.6 g/mol[Trp(O)25]-Semaglutide
<p>Semaglutide impurity.</p>Formule :C187H291N45O60Masse moléculaire :4,129.64 g/molBromfenac Related Compound A
CAS :<p>Bromfenac Related Compound A is a chemical impurity, which is often encountered during the synthesis and formulation of bromfenac, a non-steroidal anti-inflammatory drug (NSAID). This compound arises as a byproduct in the chemical synthetic pathway utilized in the production of bromfenac, necessitating stringent analytical methods to ensure product purity and compliance with pharmaceutical standards.The mode of action for Bromfenac Related Compound A itself is not typically characterized, as it is primarily the parent compound, bromfenac, that is pharmacologically active. Bromfenac works by inhibiting cyclooxygenase enzymes (COX-1 and COX-2) that mediate inflammatory processes. However, the related compound is investigated to understand the synthesis intricacies and to refine processes that limit its formation.Understanding and controlling the levels of Bromfenac Related Compound A is crucial in pharmaceutical applications, as the presence of impurities can affect the efficacy, safety, and overall quality of the drug product. Analytical chemists and pharmaceutical scientists study this compound extensively using chromatographic and spectroscopic techniques to ensure drug safety and compliance with regulatory guidelines.</p>Formule :C15H10BrNO4Masse moléculaire :348.15 g/molSitagliptin impurity E
CAS :<p>Sitagliptin impurity E is an inhibitor of dipeptidyl peptidase-4 (DPP-IV) that is used as a hypoglycemic agent. Sitagliptin impurity E has been shown to increase the glucose-lowering effect in diabetic patients with type 2 diabetes mellitus. It is also effective in reducing postprandial glucose and insulin levels. Sitagliptin impurity E has been shown to increase the concentration of insulin in plasma for up to 24 hours after administration, which suggests that it may be useful for the treatment of metabolic disorders such as obesity and type 2 diabetes mellitus.</p>Formule :C16H15F6N5ODegré de pureté :Min. 95%Masse moléculaire :407.31 g/molAnhydro abiraterone
CAS :Produit contrôlé<p>Anhydro abiraterone is a metabolite of abiraterone, which is a drug used in the treatment of prostate cancer. It has been shown to be active in the inhibition of human cytochrome P450 and has been found to be an impurity in commercial preparations of abiraterone. Anhydro abiraterone is almost insoluble in water, but can be purified by recrystallization from ethanol.</p>Formule :C24H29NDegré de pureté :Min. 95%Couleur et forme :PowderMasse moléculaire :331.49 g/molAcarbose EP Impurity F
CAS :<p>Acarbose EP Impurity F is an analytical impurity that is found in Acarbose EP, a drug product. Acarbose EP Impurity F is a synthetic compound and is not present in any natural products. The CAS number for this impurity is 83116-09-0. Acarbose EP Impurity F has been shown to be pharmacologically active in animal studies, but the specific activity of this impurity has not been determined. Acarbose EP Impurity F is used as an impurity standard in HPLC analysis of Acarbose EP and as a custom synthesis. Acarbose EP Impurity F may also be used as a research and development phase, niche product or as a drug development research compound.</p>Formule :C31H53NO23Degré de pureté :Min. 95%Masse moléculaire :807.75 g/molDutasteride EP impurity D
CAS :<p>Please enquire for more information about Dutasteride EP impurity D including the price, delivery time and more detailed product information at the technical inquiry form on this page</p>Formule :C27H28F6N2O2Degré de pureté :Min. 95%Masse moléculaire :526.51 g/molTriethylene glycol flufenamate
CAS :<p>Etofenamate impurity</p>Formule :C20H22F3NO5Degré de pureté :Min. 95%Couleur et forme :Clear LiquidMasse moléculaire :413.39 g/molGS 441524 triphosphate
CAS :<p>Triphosphorylated form of an antiviral nucleoside analog with activity against zoonotic feline infectious peritonitis virus (FIPV) and severe acute respiratory syndrome (SARS) virus from Coronaviridae family. The compound is the biologically active form of the GS 441524 prodrug and being triphosphorylated, it competes with natural nucleoside triphosphates in cells and interferes with viral RNA synthesis. Made to order.</p>Formule :C12H12N5O13P3·4NaDegré de pureté :(31P-Nmr) Min. 95 Area-%Couleur et forme :White PowderMasse moléculaire :531.20 g/molN1,N2-Bis[2-(diethylamino)ethyl]ethanediamide
CAS :<p>Please enquire for more information about N1,N2-Bis[2-(diethylamino)ethyl]ethanediamide including the price, delivery time and more detailed product information at the technical inquiry form on this page</p>Formule :C14H30N4O2Degré de pureté :Min. 95%Masse moléculaire :286.41 g/mol13-O-Desmethyl tacrolimus
CAS :<p>Tacrolimus is a macrolide immunosuppressant that is used to prevent organ rejection in transplant patients. It binds to the cytosolic protein, FKBP-12, which prevents calcineurin from dephosphorylating and activating nuclear factor of activated T cells (NFAT). Tacrolimus inhibits the production of IL-2 and other cytokines by T cells, suppressing proliferation. Tacrolimus has been shown to be bioequivalent when administered orally or intravenously. Bioavailability may be increased when taken with food.</p>Formule :C43H67NO12Degré de pureté :90%MinCouleur et forme :PowderMasse moléculaire :789.99 g/mol(S,R)-Cis-clopidogrel-mp derivative
CAS :<p>Please enquire for more information about (S,R)-Cis-clopidogrel-mp derivative including the price, delivery time and more detailed product information at the technical inquiry form on this page</p>Formule :C25H26ClNO6SDegré de pureté :Min. 95%Masse moléculaire :504 g/molEmpagliflozin impurity 25
CAS :<p>Please enquire for more information about Empagliflozin impurity 25 including the price, delivery time and more detailed product information at the technical inquiry form on this page</p>Formule :C13H9BrClFDegré de pureté :Min. 95%Couleur et forme :PowderMasse moléculaire :299.57 g/mol2,2'-(Thiobis(2-hydroxy-5,1-phenylene))bis(4H-benzo[e][1,3]oxazin-4-one)
CAS :<p>Please enquire for more information about 2,2'-(Thiobis(2-hydroxy-5,1-phenylene))bis(4H-benzo[e][1,3]oxazin-4-one) including the price, delivery time and more detailed product information at the technical inquiry form on this page</p>Formule :C28H16N2O6SDegré de pureté :Min. 95%Masse moléculaire :508.5 g/molIndospicine
CAS :<p>Indospicine is a non-proteinogenic amino acid, which is a bioactive compound derived from certain plants, particularly members of the genus *Indigofera*. This compound's mode of action is rooted in its ability to interfere with normal protein synthesis and metabolism within hepatocytes, leading to hepatotoxic effects. Indospicine functions by incorporating itself into proteins in place of arginine, subsequently causing cellular dysfunction and liver damage through mechanisms that are still being elucidated.Uses and applications of indospicine primarily concern its implications in veterinary science and toxicological studies. In livestock that consume *Indigofera*-contaminated feed, indospicine accumulation can result in significant hepatic pathology, affecting meat quality and animal health. Understanding its mechanistic pathways is crucial for developing strategies to mitigate its effects. Research into indospicine is vital for assessing the risk to animals, particularly in regions where *Indigofera* species proliferate, and for formulating guidelines to ensure safe agricultural practices. Such studies also help illuminate broader biochemical pathways involving amino acid substitution and protein synthesis disruption.</p>Formule :C7H15N3O2Degré de pureté :Min. 95%Couleur et forme :PowderMasse moléculaire :173.21 g/mol11,11'-(1,4-Piperazinediyl)bis-dibenzo[b,f][1,4]thiazepine
CAS :<p>11,11'-(1,4-Piperazinediyl)bis-dibenzo[b,f][1,4]thiazepine is a molecule that inhibits the replication of DNA and RNA in viruses. The structure of 11,11'-(1,4-Piperazinediyl)bis-dibenzo[b,f][1,4]thiazepine has been determined by X-ray crystallography. Hepatocyte cells were used for this study because they are important for the metabolism of drugs. This molecule binds to serine proteases and prevents them from functioning properly. It also inhibits the replication of hepatitis C virus and human immunodeficiency virus type 1 (HIV-1). 11,11'-(1,4-Piperazinediyl)bis-dibenzo[b,f][1,4]thiazepine can be used as a template for designing other molecules with antiviral</p>Formule :C30H24N4S2Degré de pureté :Min. 95%Couleur et forme :Yellow SolidMasse moléculaire :504.67 g/molAtorvastatin calcium trihydrate EP Impurity G
CAS :<p>Atorvastatin is a drug that belongs to the class of statins. It is used for the treatment of high cholesterol levels and other related diseases, such as cardiovascular disease. Atorvastatin calcium trihydrate EP Impurity G is an impurity that may be present in atorvastatin calcium trihydrate. This compound has not been found to have any pharmacological activity.</p>Formule :C34H37FN2O5Degré de pureté :Min. 95%Couleur et forme :PowderMasse moléculaire :572.67 g/mol2-(Sulfoacetamido) dimoxystrobin acetic acid
CAS :<p>2-(Sulfoacetamido) dimoxystrobin acetic acid is a compound that has been extensively studied for its various properties. It is known to have a mass spectrum similar to triclosan and has been found to inhibit the production of interleukin-6, a pro-inflammatory cytokine. This compound has also shown promise as a monoclonal antibody and has shown inhibitory effects on the growth of hepatocytes by blocking the action of growth factors. Additionally, it acts as a cdk4/6 inhibitor, which is important in regulating cell cycle progression. The presence of glycine and phycocyanin in this compound suggests potential hydrogen bonding interactions, while the amide group indicates its ability to form stable complexes with other compounds. The racemase activity exhibited by this compound may contribute to its biological activity, while its interaction with β-catenin suggests potential involvement in cellular signaling pathways. Overall, 2-(Sulfoacetamido) dim</p>Formule :C12H15NO6SDegré de pureté :Min. 95%Masse moléculaire :301.32 g/molEthyl 4-(8-chloro-11H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-ylidene)piperidine-1-carboxylate
CAS :<p>Ethyl 4-(8-chloro-11H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-ylidene)piperidine-1-carboxylate is a synthetic compound that belongs to the class of piperidines. It is a metabolite of ethyl 4-[(8-chloro-2,3,4,7-tetrahydrobenzo[c]chromen-3-ylidene)amino]piperidine-1carboxylate and has been shown to have an antiinflammatory effect in animal models. Ethyl 4-(8-chloro-11H benzo[5,6]cyclohepta[1,2 b]pyridin 11 ylidene) piperidine 1 carboxylate has been used as an analytical standard for HPLC and as an impurity standard for API.</p>Formule :C22H21ClN2O2Degré de pureté :Min. 95%Masse moléculaire :380.9 g/mol2-Amino-5,6-dichloro-3(4H)-quinazoline acetic acid
CAS :<p>This is a synthetic, impurity standard for 2-Amino-5,6-dichloro-3-(4H)-quinazoline acetic acid (CAS No. 1159977-03-3) that can be used in the drug product development process. This product is available as a custom synthesis and as an analytical standard for HPLC. It is also available as a pharmacopoeia grade material. The compound has been shown to have niche applications in metabolism studies and natural products research.</p>Formule :C10H9Cl2N3O2Degré de pureté :Min. 95%Masse moléculaire :274.1 g/molMetoclopramide N4-β-D-glucuronide
CAS :<p>Metoclopramide N4-β-D-glucuronide is an analog of metoclopramide, a medication used to treat nausea and vomiting. This compound has been found in human urine and has shown potential as an anticancer agent. It works by inhibiting kinases, which are enzymes involved in cell signaling pathways that regulate cell growth and division. Metoclopramide N4-β-D-glucuronide has been studied for its ability to inhibit the growth of cancer cells and induce apoptosis (cell death) in Chinese hamster ovary cells. It may have potential as a medicinal inhibitor of protein kinase activity for cancer treatment.</p>Formule :C20H30ClN3O8Degré de pureté :Min. 95%Masse moléculaire :475.9 g/mol(-)-Sabinene
CAS :<p>(-)-Sabinene is a natural compound found in urine and various medicinal plants, including Chinese herbs. It has been identified as an analog of another natural compound that exhibits potent anticancer activity. (-)-Sabinene has been shown to inhibit the activity of certain proteins involved in cell cycle regulation and apoptosis, which are important processes for the growth and survival of cancer cells. In addition, (-)-Sabinene has been found to have inhibitory effects on tumor kinase activity, making it a promising candidate for the development of new anticancer drugs. Studies have shown that (-)-Sabinene can effectively inhibit the growth of various types of cancer cells, making it a potential therapeutic agent for the treatment of cancer.</p>Formule :C10H16Degré de pureté :Min. 95%Couleur et forme :Clear LiquidMasse moléculaire :136.23 g/molMethacycline
CAS :<p>Methacycline, a tetracycline antibiotic, inhibits bacterial protein synthesis and effectively suppresses epithelial-mesenchymal transition (EMT). It blocks EMT in vitro and inhibits fibrogenesis in vivo without directly affecting the TGF-β1Smad signaling pathway. As an antimicrobial agent, Methacycline holds potential for research in pulmonary fibrosis.</p>Formule :C22H22N2O8Couleur et forme :SolidMasse moléculaire :442.427-(4-Fluorophenyl)hexahydro-b,7-dihydroxy-1b-(1-methylethyl)-7a-phenyl-1a-[(phenylamino)carbonyl]-3H-oxireno[3,4]pyrrolo[2,1-b][1,3] oxazine-3-butanoic acid
CAS :<p>7-(4-Fluorophenyl)hexahydro-b,7-dihydroxy-1b-(1-methylethyl)-7a-phenyl-1a-[(phenylamino)carbonyl]-3H-oxireno[3,4]pyrrolo[2,1-b][1,3] oxazine-3-butanoic acid is a synthetic drug product with a purity of >98%. It is an impurity standard for HPLC methods. This compound has been studied extensively in metabolism studies and pharmacological assays. 7-(4-Fluorophenyl)hexahydro-b,7-dihydroxy-1b-(1-methylethyl)-7a -phenyl 1a-[(phenylamino)carbonyl]-3H -oxireno[3,4]pyrrolo[2,1 -</p>Formule :C33H35FN2O7Degré de pureté :Min. 95%Masse moléculaire :590.64 g/molDopachrome
CAS :<p>Dopachrome is an analog that has been studied for its potential as an anticancer agent. It works by inhibiting protein kinases, which are enzymes that play a key role in tumor growth and progression. Dopachrome has shown promise as an inhibitor of cancer cell growth in both urine and human cells. In medicinal studies, it has been found to induce apoptosis, or programmed cell death, in Chinese hamster ovary cells. These findings suggest that dopachrome may have therapeutic potential as a cancer treatment. Further research is needed to fully understand the mechanisms of action and potential side effects of this promising compound.</p>Formule :C9H7NO4Degré de pureté :Min. 95%Masse moléculaire :193.16 g/mol(R,R)-(+)-Homoanatoxin A hydrochloride
CAS :<p>(R,R)-(+)-Homoanatoxin A hydrochloride is a potent inhibitor of protein phosphatases and has been shown to induce apoptosis in human cell lines. It has potential as an anticancer agent due to its ability to inhibit the growth and proliferation of cancer cells by inducing cell cycle arrest and cell death. This compound has been isolated from Chinese medicinal herbs and has shown promising results in inhibiting tumor growth in animal models. Additionally, (R,R)-(+)-Homoanatoxin A hydrochloride can be detected in urine samples of cancer patients, suggesting its potential as a biomarker for cancer diagnosis and monitoring treatment efficacy. Overall, this compound shows great promise as a novel therapeutic agent for the treatment of various types of cancers.</p>Formule :C11H17NO•HClDegré de pureté :Min. 95%Couleur et forme :PowderMasse moléculaire :215.72 g/mol11α-Hydroxyandrosta-1,4-dien-3,17-dione
CAS :Produit contrôlé<p>11α-Hydroxyandrosta-1,4-dien-3,17-dione is an analog of tolvaptan that acts as a kinase inhibitor. It has been shown to inhibit the growth of cancer cells and tumors in humans by inducing apoptosis through the inhibition of protein kinases. This compound has also been found in Chinese urine and is currently being studied as a potential anticancer drug. Additionally, 11α-Hydroxyandrosta-1,4-dien-3,17-dione has been shown to be effective against a variety of kinase inhibitors, making it a promising candidate for future cancer treatment options.</p>Formule :C19H24O3Degré de pureté :Min. 95%Couleur et forme :PowderMasse moléculaire :300.4 g/mol7,8,8a,9a-Tetrahydrobenzo[1,12]tetrapheno[10,11-b]oxirene-7,8-diol
CAS :<p>7,8,8a,9a-Tetrahydrobenzo[1,12]tetrapheno[10,11-b]oxirene-7,8-diol is a potent inhibitor of polymerase chain reaction (PCR) that is synthesized by a chemical reaction. It inhibits the activity of c-jun phosphorylation and DNA synthesis in HL60 cells. 7,8,8a,9a-Tetrahydrobenzo[1,12]tetrapheno[10,11-b]oxirene-7,8-diol is also an apoptosis inducer for HL60 cells. This agent has been shown to induce apoptosis by binding to DNA template and inhibiting mitochondrial functions. The mechanism of action for this compound is not fully understood but may involve mitochondrial membrane potential and multivariate logistic regression analysis.</p>Formule :C20H14O3Degré de pureté :Min. 95%Masse moléculaire :302.3 g/mol1-(4-Fluorophenyl)-4-[(6bS,10aR)-2,3,6b,9,10,10a-hexahydro-3-methyl-1H-pyrido[3′,4′:4,5]pyrrolo[1,2,3-de]quinoxalin-8(7H)-yl]-1-buta none
CAS :<p>Please enquire for more information about 1-(4-Fluorophenyl)-4-[(6bS,10aR)-2,3,6b,9,10,10a-hexahydro-3-methyl-1H-pyrido[3′,4′:4,5]pyrrolo[1,2,3-de]quinoxalin-8(7H)-yl]-1-buta none including the price, delivery time and more detailed product information at the technical inquiry form on this page</p>Formule :C24H28FN3OMasse moléculaire :393.5 g/mol9,17-Dihydroxycorticosterone 21-acetate
CAS :Produit contrôlé<p>Please enquire for more information about 9,17-Dihydroxycorticosterone 21-acetate including the price, delivery time and more detailed product information at the technical inquiry form on this page</p>Formule :C23H32O7Degré de pureté :Min. 95%Masse moléculaire :420.5 g/molDoxorubicin Dimer Impurity-1
<p>Doxorubicin Dimer Impurity-1 is a drug product that is used as an HPLC standard. It is a metabolite of doxorubicin and has been shown to inhibit DNA synthesis in vitro. This impurity has been detected in the drug product using HPLC, and the purity of this impurity is greater than 98%. Doxorubicin Dimer Impurity-1 is a synthetic compound that has not been found in natural sources. It has been shown to be metabolized by human enzymes, such as esterases, glucuronidases, glutathione reductase, cytochrome P450 enzymes, and glucuronic acid conjugates. Doxorubicin Dimer Impurity-1 may also have anti-inflammatory properties due to its ability to inhibit prostaglandin synthesis.</p>Formule :C54H56N2O21Degré de pureté :Min. 95%Masse moléculaire :1,069.02 g/molN-Nitroso N-Desmethyl Nizatidine Solution (1 mL )
Compounds containing an unfused thiazole ring (whether or not hydrogenated) in the structureFormule :C11H18N6O3S2Couleur et forme :Colorless LiquidMasse moléculaire :346.08818Dioctyl Methylphosphonate
CAS :Containing a phosphorus atom to which one methyl, ethyl, n-propyl or isopropyl group is bonded but no further carbon atoms, non-halFormule :C17H37O3PMasse moléculaire :320.24803N-Nitroso Acebutolol Solution (1 mL )
Compounds with other nitrogen function, nesoiFormule :C18H27N3O5Couleur et forme :Colorless LiquidMasse moléculaire :365.19507N-Nitroso Desmethyl Rizatriptan Solution (1 mL )
Heterocyclic compounds with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFormule :C14H16N6OCouleur et forme :Light Yellow LiquidMasse moléculaire :284.13856N-Nitroso Desmethyl Escitalopram Solution (1 mL )
Aromatic heterocyclic compounds with oxygen hetero-atom(s) only, nesoiFormule :C19H18FN3O2Masse moléculaire :339.1383Octadecamethylcyclononasiloxane
CAS :Organo-inorganic compounds, nesoiFormule :C18H54O9Si9Masse moléculaire :666.16912N-Nitroso N-Ethyl Valacyclovir Solution (1 mL )
Compounds containing a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, nesoiFormule :C15H23N7O5Masse moléculaire :381.17607N-Nitroso Ramipril Solution (1 mL )
Heterocyclic compounds with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFormule :C23H31N3O6Couleur et forme :Colorless LiquidMasse moléculaire :445.22129N-Nitroso Lapatinib Solution (1 mL )
Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C29H25ClFN5O5SMasse moléculaire :609.12494,6-Dimethyldodecane
CAS :Saturated acyclic hydrocarbons, excluding ethane and butaneFormule :C14H30Masse moléculaire :198.23475Deutero N-Nitrosomethylaminobutyric Acid (NMBA-d3) Solution (1 mL )
CAS :Isotopes, except those of hdg 2844; compounds, inorganic or organic, of such isotopes, whether or not chemically defined, nesoiFormule :C5H7D3N2O3Couleur et forme :Colorless LiquidMasse moléculaire :149.08797N-Nitroso N-Desmethyl Pheniramine Solution (1 mL )
Compounds containing an unfused pyridine ring in the structure, nesoiFormule :C15H17N3OCouleur et forme :Colorless LiquidMasse moléculaire :255.137162-Benzyl-2-(dimethylamino)-1-[4-(morpholin-4-yl)phenyl]butan-1-one (2-Benzyl-2-(dimethylamino)-1-(4-morpholinophenyl)butan-1-one)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C23H30N2O2Couleur et forme :White Crystalline PowderMasse moléculaire :366.23073N-Nitroso Propafenone Solution (1 mL )
Compounds with other nitrogen function, nesoiFormule :C21H26N2O4Couleur et forme :Colorless LiquidMasse moléculaire :370.18926N-Nitroso Brinzolamide Solution (1 mL ) ((R)-4-(ethyl(nitroso)amino)-2-(3-methoxypropyl)-3,4-dihydro-2H-thieno[3,2-e][1,2]thiazine-6-sulfonamide 1,1-dioxide)
Sulfonamides, nesoiFormule :C12H20N4O6S3Masse moléculaire :412.0545Dodecylcyclohexane
CAS :Cyclanes, cyclenes and cycloterpenes, excluding cyclohexaneFormule :C18H36Couleur et forme :Colorless LiquidMasse moléculaire :252.2817Eicosyl Ferulate
CAS :Carboxylic acids with additional oxygen function and their anhydrides, halides, peroxides etc, nesoiFormule :C30H50O4Masse moléculaire :474.37091N-Nitroso Desmethyl Citalopram Solution (1 mL )
Aromatic heterocyclic compounds with oxygen hetero-atom(s) only, nesoiFormule :C19H18FN3O2Masse moléculaire :339.1383N-Nitroso N-Methyl Valacyclovir Solution (1 mL ) (2-((2-amino-6-oxo-1,6-dihydro-9H-purin-9-yl)methoxy)ethyl N-methyl-N-nitroso-L-valinate)
Compounds containing a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, nesoiFormule :C14H21N7O5Masse moléculaire :367.16042N-Nitroso N-Desmethyl Tamoxifen Solution (1 mL )
Compounds with other nitrogen function, nesoiCouleur et forme :Colorless LiquidHexadecane
CAS :Saturated acyclic hydrocarbons, excluding ethane and butaneFormule :C16H34Masse moléculaire :226.26605N-Nitroso Hydrochlorothiazide Solution (1 mL )
CAS :Sulfonamides, nesoiFormule :C7H7ClN4O5S2Masse moléculaire :325.95464N-Nitroso Desmethyl (E)-Doxepin Solution (1 mL )
Aromatic heterocyclic compounds with oxygen hetero-atom(s) only, nesoiFormule :C18H18N2O2Masse moléculaire :294.13683N-Nitroso N,N'-Dibenzylethanediamine Solution (1 mL ) (N-Benzyl-N-[2-(benzylamino)ethyl]nitrosamine)
Compounds with other nitrogen function, nesoiFormule :C16H19N3OMasse moléculaire :269.15281N-Nitroso Desmethyl Dexchlorpheniramine Solution (1 mL )
Compounds containing an unfused pyridine ring in the structure, nesoiFormule :C15H16ClN3OMasse moléculaire :289.098192-Phenylphenol ([1,1'-Biphenyl]-2-ol)
CAS :Monophenols, nesoiFormule :C12H10OCouleur et forme :White SolidMasse moléculaire :170.073162-Methyl-4'-(methylthio)-2-morpholinopropiophenone
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C15H21NO2SCouleur et forme :White PowderMasse moléculaire :279.1293N-Nitroso N-Desmethyl Pyrilamine Solution (1 mL )
Compounds containing an unfused pyridine ring in the structure, nesoiFormule :C16H20N4O2Masse moléculaire :300.15863N-Nitroso Desmethyl Carbinoxamine Solution (1 mL )
Compounds containing an unfused pyridine ring in the structure, nesoiN-Nitroso N-Desmethyl Methylene Blue Solution (1 mL )
Compounds (excluding drugs) containing a phenothiazine ring-system (whether or not hydrogenated), not further fusedFormule :C15H15ClN4OSMasse moléculaire :334.06551N-Nitroso Deschloro Carbinoxamine Solution (1 mL )
Compounds containing an unfused pyridine ring in the structure, nesoiFormule :C15H17N3O2Masse moléculaire :271.13208N-Nitroso N-Desmethyl Terbinafine Solution (1 mL )
Compounds with other nitrogen function, nesoiFormule :C20H22N2OMasse moléculaire :306.17321N-Nitroso Desmethyl Chlorpromazine Solution (1 mL )
CAS :Compounds (excluding drugs) containing a phenothiazine ring-system (whether or not hydrogenated), not further fusedFormule :C16H16ClN3OSMasse moléculaire :333.07026N-Nitroso N-Desmethyl Venlafaxine Solution (1 mL ) (N-((1R,2S)-1-hydroxy-1-phenylpropan-2-yl)-N-methylnitrous amide)
CAS :Compounds with other nitrogen function, nesoiFormule :C16H24N2O3Masse moléculaire :292.17869N-Nitroso Trimetazidine Solution (1 mL )
CAS :Compounds containing a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, nesoiFormule :C14H21N3O4Masse moléculaire :295.15321N-Nitroso N-Desmethyl Doxylamine Solution (1 mL ) (N-Methyl-N-[2-[1-phenyl-1-(pyridin-2-yl)ethoxy]ethyl]nitrous amide)
Compounds containing an unfused pyridine ring in the structure, nesoiFormule :C16H19N3O2Masse moléculaire :285.14773Ethylene Sebacate
CAS :Azelaic acid, sebacic acid, their salts and estersFormule :C12H20O4Masse moléculaire :228.13616N-Nitroso Fenfluramine Solution (1 mL (N-Ethyl-N-(1-(3-(trifluoromethyl)phenyl)propan-2-yl)nitrous amide))
CAS :Compounds with other nitrogen function, nesoiFormule :C12H15F3N2OMasse moléculaire :260.11365N-Nitroso N-Desmethyl Promethazine Solution (1 mL )
CAS :Compounds (excluding drugs) containing a phenothiazine ring-system (whether or not hydrogenated), not further fusedFormule :C16H17N3OSMasse moléculaire :299.10923N-Nitroso Desmethyl Cidoxepin Solution (1 mL )
Aromatic heterocyclic compounds with oxygen hetero-atom(s) only, nesoiFormule :C18H18N2O2Masse moléculaire :294.136834-Methyloctane
CAS :Saturated acyclic hydrocarbons, excluding ethane and butaneFormule :C9H20Masse moléculaire :128.1565N-Nitroso N-Desmethyl Ranitidine Solution (1 mL )
Compounds containing an unfused furan ring, whether or not hydrogenated, in the structure, nesoiFormule :C12H19N5O4SMasse moléculaire :329.11578N-Nitroso Vilanterol Solution (1 mL )
Compounds with other nitrogen function, nesoiFormule :C24H32Cl2N2O6Masse moléculaire :514.16374Nitrophenylchlorothiophene Carboxylate (4-nitrophenyl 5-chlorothiophene-2-carboxylate)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C11H6ClNO4SCouleur et forme :White Off-White SolidMasse moléculaire :282.97061Diisobutyl Carbonate
CAS :Esters of other inorganic acids of nonmetals & their salts, their halogenated/sulfonated/nitrated/nitrosated derivs, except of hydrogen halides, nesoiFormule :C9H18O3Masse moléculaire :174.12559(11Z)-11-Eicosenamide
CAS :Acyclic amides (including acyclic carbamates) and their derivatives and salts thereof, nesoiFormule :C20H39NOMasse moléculaire :309.30316N,N'-Dinitrosopiperazine Solution (1 mL )
CAS :Compounds containing a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, nesoiFormule :C4H8N4O2Masse moléculaire :144.06473Monobutyl Phthalate (2-(Butoxycarbonyl)benzoic acid)
CAS :Formule :C12H14O4Couleur et forme :White PowderMasse moléculaire :222.089212-Methyloctacosane
CAS :Saturated acyclic hydrocarbons, excluding ethane and butaneFormule :C29H60Masse moléculaire :408.4695N-Nitroso Lorcaserin Solution (1 mL )
CAS :Heterocyclic compounds with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFormule :C11H13ClN2OMasse moléculaire :224.07164N-Nitroso N-Desmethyl Rivastigmine Solution (1 mL )
CAS :Compounds with other nitrogen function, nesoiFormule :C13H19N3O3Masse moléculaire :265.14264Butylphenyl Methylpropional
CAS :Cyclic aldehydes without other oxygen function, odoriferous or flavoring compoundsFormule :C14H20OMasse moléculaire :204.15142N-Nitroso Sitagliptin Amine (NTTP) Solution (1 mL ) (7-nitroso-3-(trifluoromethyl)-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazine)
CAS :Compounds containing a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, nesoiFormule :C6H6F3N5OCouleur et forme :Colorless LiquidMasse moléculaire :221.05244N-Nitroso Desipramine Solution (1 mL ) (N-[3-(10,11-Dihydro-5H-dibenzo[b,f]azepin-5-yl)propyl]-N-methylnitrous amide)
CAS :Heterocyclic compounds with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFormule :C18H21N3OMasse moléculaire :295.16846N-Nitroso Duloxetine Solution (1 mL ) (N-Methyl-3-(naphthalen-1-yloxy)-3-(thiophen-2-yl)-N-nitrosopropan-1-amine)
CAS :Diagnostic or lab reagents on a backing, prepared diagnostic or lab reagents whether or not on a backing, whether or not in the form of kits, nesoiFormule :C18H18N2O2SCouleur et forme :Colorless LiquidMasse moléculaire :326.10891-Azabicyclo[2.2.2]octan-3-one, hydrochloride (1:1)
CAS :Formule :C7H12ClNODegré de pureté :98%Couleur et forme :SolidMasse moléculaire :161.6293(1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone
CAS :Formule :C16H19NODegré de pureté :97%Couleur et forme :SolidMasse moléculaire :241.32815999999997ROSE BENGAL
CAS :Formule :C20H2Cl4I4Na2O5Degré de pureté :95%+Couleur et forme :SolidMasse moléculaire :1017.6363Hydrotalcite
CAS :Formule :CH24Al2Mg6O23Degré de pureté :95%Couleur et forme :SolidMasse moléculaire :603.98053599999981,2-Benzisoxazole-4,5,6,7-d4-3-methanesulfonamide
CAS :Formule :C8H4D4N2O3SDegré de pureté :CP:95%,95 atom % DCouleur et forme :SolidMasse moléculaire :216.2504C3
CAS :Formule :C24H39LiN7O17P3SDegré de pureté :85%Couleur et forme :SolidMasse moléculaire :829.5304THIONICOTINAMIDE ADENINE DINUCLEOTIDE
CAS :Formule :C21H33N7O13P2SDegré de pureté :95%Couleur et forme :SolidMasse moléculaire :685.53832-(tert-Butylamino)-1-(3-chlorophenyl)propan-1-onehydrochloride
CAS :Formule :C13H19Cl2NODegré de pureté :98%Couleur et forme :SolidMasse moléculaire :276.202110H-Thieno[2,3-b][1,5]benzodiazepine, 2-methyl-4-(4-methyl-4-oxido-1-piperazinyl)-
CAS :Formule :C17H20N4OSDegré de pureté :97%Couleur et forme :SolidMasse moléculaire :328.4319(3β,12β)-12,20-Dihydroxydammar-24-en-3-yl β-D-glucopyranoside
CAS :Formule :C36H62O8Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :622.87274-Phenyl-2-oxopyrrolidine-1-acetamide
CAS :Formule :C12H14N2O2Degré de pureté :99.58%Couleur et forme :SolidMasse moléculaire :218.251818,19-Dinorpregna-4,9,11-trien-20-yn-3-one, 13-ethyl-17-hydroxy-, (17α)-
CAS :Formule :C21H24O2Degré de pureté :99%Couleur et forme :SolidMasse moléculaire :308.4141METHYL-D3 P-TOLUENESULFONATE
CAS :Formule :C8H7D3O3SDegré de pureté :98%Couleur et forme :SolidMasse moléculaire :189.2467Ref: IN-DA00G35H
Produit arrêtéVenlafaxine
CAS :Formule :C17H27NO2Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :277.4018Ethacrynic acid
CAS :Formule :C13H12Cl2O4Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :303.1380Butanedioic acid, 2,3-dihydroxy-, (2R,3R)-rel-
CAS :Formule :C8H12O12Degré de pureté :95%Couleur et forme :LiquidMasse moléculaire :300.17374-Methylumbelliferyl β-D-cellobioside
CAS :Formule :C22H28O13Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :500.449919999999963-Ethoxy-3-oxopropanoic acid
CAS :Formule :C5H8O4Degré de pureté :96%Couleur et forme :LiquidMasse moléculaire :132.1146HYPOXANTHINE-9-β-D-ARABINOFURANOSIDE
CAS :Formule :C10H12N4O5Degré de pureté :95%Couleur et forme :SolidMasse moléculaire :268.2261PR(FOD)3
CAS :Formule :C30H33F21O6PrDegré de pureté :97.0%Couleur et forme :SolidMasse moléculaire :1029.4535(1S,2R,18R,22S,25R,28R,40R)-48-{[(2S,3R,4S,5S,6R)-3-{[(2S,4S,5S,6S)-4-amino-5-hydroxy-4,6-dimethyloxan-2-yl]oxy}-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-22-(carbamoylmethyl)-5,47-dichloro-2,18,32,35,37-pentahydroxy-19-[(2R)-4-methyl-2-(methylamino)pentanamido]-20,23,26,42,44-pentaoxo-7,13-dioxa-21,24,27,41,43-pentaazaoctacyclo[26.14.2.2^{3,6}.2^{14,17}.1^{8,12}.1^{29,33}.0^{10,25}.0^{34,39}]pentaconta-3,5,8(48),9,11,14,16,29(45),30,32,34,36,38,46,49-pentadecaene-40-carboxylic acid
CAS :Formule :C66H75Cl2N9O24Degré de pureté :95%Couleur et forme :SolidMasse moléculaire :1449.2536Ref: IN-DA00IULF
Produit arrêtéN-ACETYLMURAMYL-L-ALANYL-D-ISOGLUTAMINE
CAS :Formule :C19H32N4O11Degré de pureté :98%Masse moléculaire :492.4776Ref: IN-DA00DABS
Produit arrêtéBenzeneacetic acid, α-(methyl-d3)-4-(2-methylpropyl)- (9CI)
CAS :Formule :C13H15D3O2Degré de pureté :%Couleur et forme :SolidMasse moléculaire :209.2993Bisoprolol
CAS :Formule :C18H31NO4Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :325.44301,1'-Biphenyl, 2,3-dichloro-
CAS :Formule :C12H8Cl2Couleur et forme :SolidMasse moléculaire :223.0979Platinum, diammine[1,1-cyclobutanedi(carboxylato-kO)(2-)]-, (SP-4-2)-
CAS :Formule :C6H10N2O4PtDegré de pureté :98%Couleur et forme :SolidMasse moléculaire :369.2326Bismuth hydroxide nitrate oxide, Bi2O3 79% min
CAS :Formule :Bi5H9N4O22Degré de pureté :97%Couleur et forme :SolidMasse moléculaire :1461.9870599999988Methoxyphenamine hydrochloride
CAS :Formule :C11H18ClNODegré de pureté :99%Couleur et forme :SolidMasse moléculaire :215.7197Indacaterol
CAS :Formule :C24H28N2O3Degré de pureté :99%Couleur et forme :SolidMasse moléculaire :392.4907(Cyclohexylidenemethylene)-bis(4,1-phenylene) diacetate
CAS :Formule :C23H24O4Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :364.43431-(4-ISOBUTYLPHENYL)PROPAN-1-ONE
CAS :Formule :C13H18ODegré de pureté :97%Couleur et forme :LiquidMasse moléculaire :190.2814200000000511b-Hydroxy-androst-4-ene-3,17-dione
CAS :Formule :C19H26O3Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :302.4079DL-ALANINE-2,3,3,3-D4
CAS :Formule :C3H3D4NO2Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :93.11781,2-Benzenediol, 4-(2-aminoethyl-1,1,2,2-d4)-, hydrochloride (1:1)
CAS :Formule :C8H8ClD4NO2Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :193.6640(Trifluoromethyl)Trimethylsilane
CAS :Formule :C4H9F3SiDegré de pureté :98%Couleur et forme :LiquidMasse moléculaire :142.1950Posaconazole-d4
CAS :Formule :C37H38D4F2N8O4Degré de pureté :≥97%Couleur et forme :SolidMasse moléculaire :704.8020Torsemide
CAS :Formule :C16H20N4O3SDegré de pureté :98%Couleur et forme :SolidMasse moléculaire :348.4200Perfluoro-15-crown-5
CAS :Formule :C10F20O5Degré de pureté :98%Couleur et forme :LiquidMasse moléculaire :580.0720639999996Gadoteric acid
CAS :Formule :C16H24GdN4O8Degré de pureté :95%Couleur et forme :SolidMasse moléculaire :558.6417Trimethylamine-d9 N-Oxide
CAS :Formule :C3D9NODegré de pureté :%Couleur et forme :SolidMasse moléculaire :84.1651Phosphonic acid,[2-[[4-[(3-chloro-4-fluorophenyl)amino]-7-[[(3S)-tetrahydro-3-furanyl]oxy]-6-quinazolinyl]amino]-2-oxoethyl]-, diethyl ester
CAS :Formule :C24H27ClFN4O6PDegré de pureté :95%Couleur et forme :SolidMasse moléculaire :552.91952-(Perfluoro-n-Octyl)Ethanol
CAS :Formule :C10H5F17ODegré de pureté :95%Couleur et forme :SolidMasse moléculaire :464.1194-AZIDOBUTAN-1-OL
CAS :Formule :C4H9N3ODegré de pureté :97%Couleur et forme :LiquidMasse moléculaire :115.13385,10-Dihydro-2-methyl-4H-thieno[2,3-β][1,5]benzodiazepin-4-one (Olanzapine Impurity)
CAS :Formule :C12H10N2OSDegré de pureté :96%Couleur et forme :SolidMasse moléculaire :230.2856Mirtazapine-D3
CAS :Formule :C17H16D3N3Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :268.3713FLUPHENAZINE
CAS :Formule :C22H26F3N3OSDegré de pureté :98%Couleur et forme :SolidMasse moléculaire :437.5215Dimethylamine Hydrochloride
CAS :Formule :C2H8ClNDegré de pureté :98%Couleur et forme :SolidMasse moléculaire :81.5446Tetracosactide
CAS :Formule :C136H210N40O31SDegré de pureté :99%Couleur et forme :SolidMasse moléculaire :2933.4370Cyclic Somatostatin
CAS :Formule :C76H104N18O19S2Degré de pureté :97%Couleur et forme :LiquidMasse moléculaire :1637.87815999999951-(2-chlorophenyl)-2-[[1,1,1,3,3,3-hexadeuterio-2-(trideuteriomethyl)propan-2-yl]amino]ethanol
CAS :Formule :C12H18ClNODegré de pureté :95%Couleur et forme :SolidMasse moléculaire :227.73046-(5-Chloropyridin-2-yl)-7-hydroxy-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5-one
CAS :Formule :C11H7ClN4O2Degré de pureté :95%Couleur et forme :SolidMasse moléculaire :262.6519Chloroform-D
CAS :Formule :CCl3DDegré de pureté :98%Couleur et forme :LiquidMasse moléculaire :120.3838Methanone, [(3R)-2,3-dihydro-5-methyl-3-(4-morpholinylmethyl)pyrrolo[1,2,3-de]-1,4-benzoxazin-6-yl]-1-naphthalenyl-, methanesulfonate (1:1)
CAS :Formule :C28H30N2O6SDegré de pureté :98%Masse moléculaire :522.6126Naphtho[2,3-b]furan-2(3H)-one,3a,5,6,7,8,8a,9,9a-octahydro-5,8a-dimethyl-3-methylene-,(3aR,5S,8aR,9aR)-
CAS :Formule :C15H20O2Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :232.31817α-Hydroxy Cholesterol-D7
CAS :Formule :C27H39D7ODegré de pureté :98%Couleur et forme :SolidMasse moléculaire :393.6967Mometasone
CAS :Formule :C22H28Cl2O4Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :427.3613Luteinizing hormone-releasing factor (swine), 6-D-tryptophan-
CAS :Formule :C64H82N18O13Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :1311.4487Cholic Acid-d4
CAS :Formule :C24H36D4O5Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :412.5960S-3-(4-acetylamino-phenoxy)-2-hydroxy-2-methyl-N-(4-nitro-3-trifluoromethyl-phenyl)-propionamide
CAS :Formule :C19H18F3N3O6Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :441.3579Cyclobutanecarboxaldehyde
CAS :Formule :C5H8ODegré de pureté :95%Couleur et forme :LiquidMasse moléculaire :84.11642,6-Ntp
CAS :Formule :C17H16N2O5Degré de pureté :95%Couleur et forme :SolidMasse moléculaire :328.3193Ref: IN-DA00DFHE
Produit arrêtéGinsenoside Rg1
CAS :Formule :C42H72O14Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :801.0127Dammarane-3,12-diol, 20,25-epoxy-, (3b,12b,20R)-
CAS :Formule :C30H52O3Couleur et forme :SolidMasse moléculaire :460.73211,3-Benzenediol,4-(3,4-dihydro-8,8-dimethyl-2H,8H-benzo[1,2-b:3,4-b']dipyran-3-yl)-,(R)-
CAS :Formule :C20H20O4Degré de pureté :97%Couleur et forme :SolidMasse moléculaire :324.37042,6-Bis(1-methylethyl)phenol
CAS :Formule :C12H18ODegré de pureté :98%Couleur et forme :LiquidMasse moléculaire :178.2707Rapamycin-d3 (contains d0) Technical Grade
CAS :Formule :C51H76D3NO13Degré de pureté :≥98% deuterated forms (d1-d3),1mg/ml in ethanolCouleur et forme :SolidMasse moléculaire :917.1903Vitamin K1-d7
CAS :Formule :C31H39D7O2Degré de pureté :95%Couleur et forme :SolidMasse moléculaire :457.73891-Benzyl-3-methylpiperidin-4-one
CAS :Formule :C13H17NODegré de pureté :98%Couleur et forme :LiquidMasse moléculaire :203.2802astragaloside iv
CAS :Formule :C41H68O14Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :784.9702(8R,9S,10R,13S,14S)-10,13-Dimethyl-6-methylene-7,8,9,11,12,13,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17(10H,14H)-dione
CAS :Formule :C20H24O2Degré de pureté :99%Couleur et forme :SolidMasse moléculaire :296.40342-Phenyl-2-(piperidin-2-yl)acetamide
CAS :Formule :C13H18N2ODegré de pureté :98%Couleur et forme :SolidMasse moléculaire :218.2948Indapamide
CAS :Formule :C16H16ClN3O3SDegré de pureté :98%Couleur et forme :SolidMasse moléculaire :365.8345Vitamin B12
CAS :Formule :C63H88CoN14O14PDegré de pureté :98%Couleur et forme :SolidMasse moléculaire :1355.36521,2,3-Propanetricarboxylic acid, 2-hydroxy-, bismuth(3+) potassium salt(2:1:3)
CAS :Formule :C12H10BiK3O14Degré de pureté :97%Couleur et forme :SolidMasse moléculaire :704.4747




